NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹4,327 Cr |
| Mar2024 | ₹3,051 Cr |
| Mar2023 | ₹2,317 Cr |
| Mar2022 | ₹1,776 Cr |
| Mar2021 | ₹1,819 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,327 Cr | 41.82 | |
| Mar2024 | ₹3,051 Cr | 31.65 | |
| Mar2023 | ₹2,317 Cr | 30.45 | |
| Mar2022 | ₹1,776 Cr | -2.36 | |
| Mar2021 | ₹1,819 Cr | - | |
Compare Net Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,210.3 Cr | 1.4% | 11% | -38.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,220.0 Cr | 1.2% | 2.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,486.0 Cr | 0.9% | -2.5% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,963.0 Cr | 0.5% | -1.5% | 12.3% | Stock Analytics | |
| CIPLA | ₹121,751.0 Cr | 1.1% | -1.6% | 4.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,866.0 Cr | 2.7% | 2.9% | 3.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.4% |
11% |
-38.1% |
| SENSEX | 0.1% |
0.9% |
4.5% |
You may also like the below Video Courses